R1 RCM

RCM68

$14.31arrow_drop_up0.13%$0.01

RCM68

$14.31

arrow_drop_up0.13%$0.01

Performance History

Key Stats
Open	$14.30
Prev. Close	$14.30
EPS	-0.14
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	14.30	14.36
52 Week Range	8.87	15.12

Ratios







EPS	-0.14

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About R1 RCM (RCM)

R1 RCM Inc (RCM) is a leading provider of revenue cycle management services for healthcare providers. The company's comprehensive suite of solutions helps healthcare organizations improve their financial performance and patient experience. R1 RCM's innovative technology and proprietary analytics enable providers to optimize their revenue cycle operations, reduce costs, and accelerate cash flow. With a market cap of $X billion, RCM is a key player in the industry.

Over the past year, RCM stock has shown impressive growth, outperforming the industry average. The stock has a 52-week range of $X - $X, indicating strong volatility. Despite market fluctuations, R1 RCM has demonstrated resilience and a consistent upward trend in its stock price. Investors have been attracted to the company's strong financial performance and growth prospects.

Websitecall_made

Sector: Healthcare
Industry: Health Information Services
CEO: Mr. Lee Rivas
Headquarters: Murray
Employees: 27200
Exchange: NASDAQ

Keep an eye on R1 RCM

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is R1 RCM 's (RCM) price per share?

The current price per share for R1 RCM (RCM) is $14.31. The stock has seen a price change of $0.02 recently, indicating a 0.14% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for R1 RCM (RCM)?

For R1 RCM (RCM), the 52-week high is $15.12, which is 5.66% from the current price. The 52-week low is $8.87, the current price is 61.33% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is R1 RCM (RCM) a growth stock?

R1 RCM (RCM) has shown an average price growth of -7.23% over the past three years. It has received a score of 52 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying R1 RCM as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is R1 RCM (RCM) stock price performance year to date (YTD)?

As of the latest data, R1 RCM (RCM) has a year-to-date price change of 34.11%. Over the past month, the stock has experienced a price change of 0.49%. Over the last three months, the change has been 1.78%. Over the past six months, the figure is 16.53%. Looking at a longer horizon, the five-year price change stands at 12.85%.

help

Is R1 RCM (RCM) a profitable company?

R1 RCM (RCM) has a net income of $3.3M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 21.49% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 3.78% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.25B, with a revenue growth rate of 24.79%, providing insight into the company's sales performance and growth. The gross profit is $484.5M. Operating income is noted at $147.9M. Furthermore, the EBITDA is $484.8M.

help

What is the market capitalization of R1 RCM (RCM)?

R1 RCM (RCM) has a market capitalization of $6.04B. The average daily trading volume is 14.31, indicating the stock's liquidity and investor engagement.

News

HEALTHCARE

REVENUE CYCLE MANAGEMENT

Healthcare Revenue Cycle Management Market Size to Achieve USD 453.47 Bn by 2034

R1 RCM INC.

ENSTAR GROUP LIMITED

MERGERS AND ACQUISITIONS

SHAREHOLDER RIGHTS

Aug 12, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, ESGR on Behalf of Shareholders

MERGERS AND ACQUISITIONS

SHAREHOLDER INVESTIGATIONS

Aug 12, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Revance Therapeutics, Inc. (Nasdaq – RVNC), Greenbrook TMS, Inc. (OTC – GBNHF), R1 RCM Inc. (Nasdaq - RCM), Enstar Group Limited (Nasdaq – ESGR)

R1 RCM INC.

ENSTAR GROUP LIMITED

PREMIER FINANCIAL CORP.

THE FIRST BANCSHARES, INC.

MERGERS AND ACQUISITIONS

SHAREHOLDER INVESTIGATIONS

Aug 5, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: R1 RCM Inc. (Nasdaq - RCM), Enstar Group Limited (Nasdaq – ESGR), Premier Financial Corp. (Nasdaq – PFC), The First Bancshares, Inc. (NYSE – FBMS)

R1 RCM

TOWERBROOK CAPITAL PARTNERS

CLAYTON, DUBILIER & RICE

SALE

FAIRNESS

Aug 1, 2024

RCM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice

R1 RCM

ANALYST INSIGHTS

HEALTHCARE PROVIDER

REVENUE CYCLE MANAGEMENT

Jul 22, 2024